CLCN3 Antibody [E24D24] | Primary Antibodies

Application: Reactivity: Human, Mouse, Rat

Usage Information

Dilution
WB1:1000 IP1:50 IF1:100

Application
WB, IP, IF

Reactivity
Human, Mouse, Rat

Source
Rabbit Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW Observed MW
91 kDa 130-150 kDa
^*Why do the predicted and actual molecular weights differ? The following reasons may explain differences between the predicted and actual protein molecular weight. Post-translational modifications(e.g., phosphorylation, glycosylation); Splice variants and isoforms; Relative charge; Multimerization.

Datasheet & SDS

Biological Description

Specificity
CLCN3 Antibody [E24D24] detects endogenous levels of total CLCN3 protein.

Clone
E24D24

Synonym(s)
chloride channel 3; Chloride channel protein 3; chloride channel, voltage-sensitive 3; Chloride transporter ClC-3; chloride voltage-gated channel 3; ClC-3; CLC3; CLCN3; H(+)/Cl(-) exchange transporter 3

Background
CLCN3 (chloride voltage‑gated channel 3) is a broadly expressed ClC‑family 2Cl⁻/H⁺ exchanger that localizes to plasma membranes and intracellular vesicles, where it mediates electrogenic exchange of chloride ions for protons and contributes to acidification of endosomes and synaptic vesicles, regulation of vesicle trafficking and exocytosis, and control of neuronal excitability and smooth muscle activation. The protein is a multi‑pass membrane transporter with a ClC core domain that forms the anion/proton transport pathway and two cytosolic C‑terminal cystathionine‑β‑synthase (CBS) domains that act as regulatory modules; conserved “gating glutamate” residues within the ClC domain define CLCN3 as a proton‑coupled antiporter rather than a simple chloride channel, and the transporter functions as a homodimer, with each subunit containing an independent Cl⁻/H⁺ transport pathway. CLCN3 expression is particularly high in neuroectoderm‑derived tissues and concentrates in hippocampus, olfactory cortex, and olfactory bulb, consistent with its role in synaptic vesicle lumen acidification and transmitter loading at GABAergic terminals, where it complements vesicular H⁺‑ATPases to set the electrochemical environment required for efficient accumulation of neurotransmitters and for proper short‑term synaptic plasticity. The exchanger participates in endosomal acidification and vesicle trafficking more generally, influencing receptor recycling and degradation, and is also required for lysophosphatidic acid–activated chloride currents and fibroblast‑to‑myofibroblast differentiation, implicating CLCN3 in extracellular matrix remodeling and neointima formation during vascular injury, with roles in smooth muscle cell activation and vascular proliferative responses. Regulatory control of CLCN3 involves Ca²⁺/calmodulin‑dependent protein kinase II (CaMKII), which modulates channel activity and surface expression in glioma cells, providing a mechanism by which Ca²⁺‑dependent signaling pathways tune CLCN3‑mediated chloride fluxes and thereby affect cell volume regulation, migration, and invasive behavior in malignant glia. Identification of CLCN3 together with CLCN5 as mediators of sphingosine‑1‑phosphate–induced excitatory chloride currents in sensory neurons links the transporter to neuromodulatory lipid signaling and sensory processing, expanding its functional relevance beyond classical vesicular acidification to acute regulation of membrane potential and nociceptive signaling.

Background

CLCN3 (chloride voltage‑gated channel 3) is a broadly expressed ClC‑family 2Cl⁻/H⁺ exchanger that localizes to plasma membranes and intracellular vesicles, where it mediates electrogenic exchange of chloride ions for protons and contributes to acidification of endosomes and synaptic vesicles, regulation of vesicle trafficking and exocytosis, and control of neuronal excitability and smooth muscle activation. The protein is a multi‑pass membrane transporter with a ClC core domain that forms the anion/proton transport pathway and two cytosolic C‑terminal cystathionine‑β‑synthase (CBS) domains that act as regulatory modules; conserved “gating glutamate” residues within the ClC domain define CLCN3 as a proton‑coupled antiporter rather than a simple chloride channel, and the transporter functions as a homodimer, with each subunit containing an independent Cl⁻/H⁺ transport pathway. CLCN3 expression is particularly high in neuroectoderm‑derived tissues and concentrates in hippocampus, olfactory cortex, and olfactory bulb, consistent with its role in synaptic vesicle lumen acidification and transmitter loading at GABAergic terminals, where it complements vesicular H⁺‑ATPases to set the electrochemical environment required for efficient accumulation of neurotransmitters and for proper short‑term synaptic plasticity. The exchanger participates in endosomal acidification and vesicle trafficking more generally, influencing receptor recycling and degradation, and is also required for lysophosphatidic acid–activated chloride currents and fibroblast‑to‑myofibroblast differentiation, implicating CLCN3 in extracellular matrix remodeling and neointima formation during vascular injury, with roles in smooth muscle cell activation and vascular proliferative responses. Regulatory control of CLCN3 involves Ca²⁺/calmodulin‑dependent protein kinase II (CaMKII), which modulates channel activity and surface expression in glioma cells, providing a mechanism by which Ca²⁺‑dependent signaling pathways tune CLCN3‑mediated chloride fluxes and thereby affect cell volume regulation, migration, and invasive behavior in malignant glia. Identification of CLCN3 together with CLCN5 as mediators of sphingosine‑1‑phosphate–induced excitatory chloride currents in sensory neurons links the transporter to neuromodulatory lipid signaling and sensory processing, expanding its functional relevance beyond classical vesicular acidification to acute regulation of membrane potential and nociceptive signaling.

References
https://pubmed.ncbi.nlm.nih.gov/7665160/ https://pubmed.ncbi.nlm.nih.gov/29479306/

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%